Search results for FOXG1 antibody

FOXG1 antibody, Genetex, GTX17231

FOXG1 antibody, Genetex, GTX03427

FOXG1 antibody, Genetex, GTX134018

Anti-FOXG1 antibody, Abcam, AB18259

Anti-FOXG1 antibody (ab18259) is a rabbit polyclonal antibody and is validated for use in IHC-P, WB in firefly samples. Anti-FOXG1 antibody (ab18259) has been cited over 140 times in peer reviewed journals and is trusted by the scientific community. Abcam's high quality validation processes ensure Anti-FOXG1 antibody (ab18259) has high sensitivity and specificity. Anti-FOXG1 antibody (ab18259) has 13 independent reviews from customers. Anti-FOXG1 antibody (ab18259) specifically detects FOXG1 (UniProt ID: P55316; Molecular weight: 52kDa) and is sold in 100 µg selling sizes. FOXG1 is a critical transcription factor involved in brain development and is associated with various neurological disorders. Research indicates that mutations in FOXG1 can lead to severe developmental issues, making it a significant target for gene therapy. Understanding FOXG1's role can provide insights into potential treatments for conditions like Rett syndrome syndrome.

Anti-FOXG1 antibody, Abcam, AB3394

Anti-FOXG1 antibody [EPR18987], Abcam, AB196868

Product Specifications Anti-FOXG1 antibody [EPR18987] (ab196868) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-Fr, IHC-P, IP, WB, ChIP-Sequencing in human, mouse and rat samples. Anti-FOXG1 antibody [EPR18987] (ab196868) specifically detects FOXG1 (UniProt ID: P55316; Molecular weight: 52kDa) and is sold in 100 µL and 1 mL selling sizes. Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-FOXG1 antibody [EPR18987] (ab196868) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-FOXG1 antibody [EPR18987] (ab196868) has been cited over 16 times in peer reviewed journals and is trusted by the scientific community. Related Products Conjugation-ready, carrier free format available for antibody clone EPR18987 - ab227888 . Antibody clone EPR18987 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 647, PE, APC, HRP, Alkaline Phosphatase, Alexa Fluor® 488, Alexa Fluor® 594, Alexa Fluor® 555, Alexa Fluor® 568, Alexa Fluor® 750 ( ab270103 , ab305686 , ab305687 , ab305688 , ab308686 , ab309659 , ab310394 , ab311920 , ab312391 , ab321338 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

FOXG1 antibody, C-term, Genetex, GTX89897

HRP Anti-FOXG1 antibody [EPR18987], Abcam, AB305688

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-FOXG1 antibody [EPR18987], Abcam, AB305686

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .

APC Anti-FOXG1 antibody [EPR18987], Abcam, AB305687

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .